These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10682471)

  • 1. [Effect of mifepristone on the expression of progesterone receptor messenger RNA and protein in uterine leiomyomata].
    Sun M; Zhu G; Zhou L
    Zhonghua Fu Chan Ke Za Zhi; 1998 Apr; 33(4):227-31. PubMed ID: 10682471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
    Murphy AA; Kettel LM; Morales AJ; Roberts VJ; Yen SS
    J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of mifepristone on gene expression of epidermal growth factor in human uterine leiomyoma].
    Yang Y; Zheng S; Zhang Z
    Zhonghua Fu Chan Ke Za Zhi; 1998 Jan; 33(1):38-9. PubMed ID: 10682457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of mifepristone on estrogen and progestin receptors in human uterine leiomyoma].
    Wang H; Jin J
    Zhonghua Fu Chan Ke Za Zhi; 2000 Feb; 35(2):79-81. PubMed ID: 11809103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RU486: pharmacology and potential use in the treatment of endometriosis and leiomyomata uteri.
    Murphy AA; Castellano PZ
    Curr Opin Obstet Gynecol; 1994 Jun; 6(3):269-78. PubMed ID: 8038415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Open-label study of ultra low-dose mifepristone for the treatment of uterine leiomyomata.
    Eisinger SH; Fiscella J; Bonfiglio T; Meldrum S; Fiscella K
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):215-8. PubMed ID: 19586708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of the effect of raloxifene and gosereline on uterine leiomyoma volume changes and estrogen receptor, progesterone receptor, bcl-2 and p53 expression immunohistochemically in premenopausal women.
    Baytur YB; Ozbilgin K; Cilaker S; Lacin S; Kurtul O; Oruc S; Koyuncu FM
    Eur J Obstet Gynecol Reprod Biol; 2007 Nov; 135(1):94-103. PubMed ID: 16973256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estradiol and progesterone binding in uterine leiomyomata and in normal uterine tissues.
    Wilson EA; Yang F; Rees ED
    Obstet Gynecol; 1980 Jan; 55(1):20-4. PubMed ID: 7352057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid receptor binding and messenger RNA expression in fibroids from untreated and gonadotrophin-releasing hormone agonist pretreated women.
    Vollenhoven BJ; Pearce P; Herington AC; Healy DL
    Clin Endocrinol (Oxf); 1994 Apr; 40(4):537-44. PubMed ID: 8187322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma.
    Leitao MM; Soslow RA; Nonaka D; Olshen AB; Aghajanian C; Sabbatini P; Dupont J; Hensley M; Sonoda Y; Barakat RR; Anderson S
    Cancer; 2004 Sep; 101(6):1455-62. PubMed ID: 15316901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of the A and B forms of the progesterone receptor messenger ribonucleic acid and protein in uterine leiomyomata and adjacent myometrium.
    Viville B; Charnock-Jones DS; Sharkey AM; Wetzka B; Smith SK
    Hum Reprod; 1997 Apr; 12(4):815-22. PubMed ID: 9159448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of the selective progesterone receptor modulator asoprisnil on the morphology of uterine tissues after 3 months treatment in patients with symptomatic uterine leiomyomata.
    Williams AR; Critchley HO; Osei J; Ingamells S; Cameron IT; Han C; Chwalisz K
    Hum Reprod; 2007 Jun; 22(6):1696-704. PubMed ID: 17339234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression profile of the tumorigenic factors associated with tumor size and sex steroid hormone status in uterine leiomyomata.
    Wei JJ; Chiriboga L; Mittal K
    Fertil Steril; 2005 Aug; 84(2):474-84. PubMed ID: 16084893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene and protein expression of progesterone receptor isoforms A and B, p53 and p21 in myometrium and uterine leiomyoma.
    Lora V; Grings AO; Capp E; von Eye Corleta H; Brum IS
    Arch Gynecol Obstet; 2012 Jul; 286(1):119-24. PubMed ID: 22350293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of estrogen and progesterone receptors in the myometrium and leiomyoma tissue after suppression of estrogens with gonadotropin releasing hormone analogs.
    van de Ven J; Sprong M; Donker GH; Thijssen JH; Mak-Kregar S; Blankenstein MA
    Gynecol Endocrinol; 2001 Dec; 15 Suppl 6():61-8. PubMed ID: 12227888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of human and rat uterine leiomyomata: identification of a dysregulated mammalian target of rapamycin pathway.
    Crabtree JS; Jelinsky SA; Harris HA; Choe SE; Cotreau MM; Kimberland ML; Wilson E; Saraf KA; Liu W; McCampbell AS; Dave B; Broaddus RR; Brown EL; Kao W; Skotnicki JS; Abou-Gharbia M; Winneker RC; Walker CL
    Cancer Res; 2009 Aug; 69(15):6171-8. PubMed ID: 19622772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased progesterone receptor expression in uterine leiomyoma: correlation with age, number of leiomyomas, and clinical symptoms.
    Tsigkou A; Reis FM; Lee MH; Jiang B; Tosti C; Centini G; Shen FR; Chen YG; Petraglia F
    Fertil Steril; 2015 Jul; 104(1):170-5.e1. PubMed ID: 26006736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progesterone and mifepristone regulate L-type amino acid transporter 2 and 4F2 heavy chain expression in uterine leiomyoma cells.
    Luo X; Yin P; Reierstad S; Ishikawa H; Lin Z; Pavone ME; Zhao H; Marsh EE; Bulun SE
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4533-9. PubMed ID: 19808856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mifepristone for treatment of uterine leiomyoma. A prospective randomized placebo controlled trial.
    Engman M; Granberg S; Williams AR; Meng CX; Lalitkumar PG; Gemzell-Danielsson K
    Hum Reprod; 2009 Aug; 24(8):1870-9. PubMed ID: 19389793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of mac25 mRNA in uterine leiomyomata compared with adjacent myometrium.
    Kim JG; Kim MH; Kim IS; Moon SY; Kang SB; Lee HP; Lee JY
    Am J Reprod Immunol; 2000 Jan; 43(1):53-7. PubMed ID: 10698042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.